Alimera Sciences (ALIM) Competitor Comparison
We are evaluating the key criteria listed to compare Alimera Sciences (ALIM) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
34 / 54Gross Profits
0 / 39Total Revenue
39 / 50EBITDA
30 / 53Free Cashflow
51 / 54Quick Ratio
16 / 54Earnings per Share
9 / 54Dividend yield
0 / 5Total Cash
48 / 54Performance 3 years
12 / 54Performance 5 years
13 / 54Performance 10 years
12 / 54Linearity 3 years
6 / 54Linearity 5 years
11 / 54Linearity 10 years
10 / 54Total Rank
46 / 54Dividend Rank
40 / 54Valuation Rank
18 / 54Piotroski Rank
48 / 54Muliplier Rank
45 / 54Market Capitalization - ALIM ranking 34 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.